Influence of Lenvatinib on the Functional Reprogramming of Peripheral Myeloid Cells in the Context of Non-Medullary Thyroid Carcinoma.
Pharmaceutics
View this publicationPharmaceutics
View this publicationJournal of cardiovascular computed tomography
View this publicationThe New England journal of medicine
View this publicationScientific reports
View this publicationJHEP reports : innovation in hepatology
View this publicationMovement disorders : official journal of the Movement Disorder Society
View this publicationEuropean urology
View this publicationBMC infectious diseases
View this publicationInternational journal of molecular sciences
View this publicationMed (New York, N.Y.)
View this publication